Soluble Urokinase-Type Plasminogen Activator Receptor Is a Novel Biomarker Predicting Acute Exacerbation in COPD

International Journal of COPD - New Zealand
doi 10.2147/copd.s77654
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Soluble Urokinase-Type Plasminogen Activator Receptor Is a Novel Biomarker Predicting Acute Exacerbation in COPD

2015English

Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker for Focal Segmental Glomerulosclerosis; A Retrospective Analysis

Journal of Nephropathology
Nephrology
2018English

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea

Medicina
Medicine
2020English

Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans With CKD

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Plasma Level of Soluble Urokinase-Type Plasminogen Activator Receptor Predicts the Severity of Acute Alcohol Pancreatitis

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2017English

Urokinase Type Plasminogen Activator Receptor Expression in Colorectal Neoplasms

Gut
Gastroenterology
1998English

Ligand Binding Regions in the Receptor for Urokinase-Type Plasminogen Activator

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Full-Length Soluble Urokinase Plasminogen Activator Receptor Down-Modulates Nephrin Expression in Podocytes

Scientific Reports
Multidisciplinary
2015English

Plasminogen Activator Urokinase Receptor (PLAUR; uPAR; suPAR)

Science-Business eXchange
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy